The e19a2 BCR/ABL fusion transcript with additional chromosomal aberrations on a new case of chronic myeloid leukemia (CML) of mild type [3]

Leukemia

Volumn 15, Issue 12, 2001, Pages 2003-2004

  Bertorelle, R ^a,b   Bonaldi, L ^a,b   Bianchini, E ^c   Ramazzina, E ^c   Del Mistro, A ^a,b   Zamboni, S ^c   Chieco Bianchi, L ^a,b   Paolini, R ^c  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^c ROVIGO GENERAL HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BCR ABL PROTEIN; CYTARABINE; HYDROXYUREA;

ADULT; BONE MARROW BIOPSY; CASE REPORT; CHROMOSOME 22Q; CHROMOSOME 8Q; CHROMOSOME 9Q; CHROMOSOME ABERRATION; CHROMOSOME LOSS; CHROMOSOME TRANSLOCATION 22; CHROMOSOME TRANSLOCATION 9; CHRONIC MYELOID LEUKEMIA; CLINICAL FEATURE; COMORBIDITY; CYTOGENETICS; EPILEPSY; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; GENE REARRANGEMENT; GENOTYPE; HUMAN; LABORATORY TEST; LETTER; MALE; PERICENTRIC CHROMOSOME INVERSION; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0035195554     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402292     Document Type: Letter

References (13)

1. Neutrophilic-chronic myeloid leukemia: A distinct disease with a specific molecular marker (BCR/ABL with c3/a2 junction)
2. New type of Bcr/Abl junction in Philadelphia chromosome-positive chronic myelogenous leukemia
3. Elevated platelet count features the variant type of BCR/ABL junction in chronic myelogenous leukemia
4. A new case of chronic myeloid leukemia with c3/a2 BCR/ABL junction. It is really a distinct disease?
5. BCR/ABL transcript with an e19a2 (c3a2) junction in classical chronic myeloid leukemia
6. Typical chronic myelogenous leukemia with e19a2 junction BCR/ABL transcript
7. Establishment and molecular characterization of a novel leukemic cell line with Philadelphia chromosome expressing p230 BCR/ABL fusion protein
8. Chronic myeloid leukemia with e19a2 (c3a2) BCR/ABL fusion junction - Is it truly a benign disease?
9. An accelerated-phase CML patient with e19a2 junction of BCR/ABL gene - The first case of transplanted CML with micro bcr
10. Additional translocation (8;21)(q22;q22) in a patient with Philadelphia-positive chronic myelogenous leukemia in the blastic phase
11. P230 BCR/ABL protein may be associated with an acute leukaemia phenotype
12. Cytogenetics of chronic myelogenous leukemia
13. The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice, but have different lymphoid leukemogenic activity